These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30255656)

  • 21. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
    Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
    Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
    Wang L; Ren B; Zhuang H; Zhong Y; Nan Y
    Technol Cancer Res Treat; 2021; 20():15330338211045831. PubMed ID: 34709960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sevoflurane downregulates insulin-like growth factor-1 to inhibit cell proliferation, invasion and trigger apoptosis in glioma through the PI3K/AKT signaling pathway.
    Gao C; He XF; Xu QR; Xu YJ; Shen J
    Anticancer Drugs; 2019 Aug; 30(7):e0744. PubMed ID: 31305291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1.
    Zheng K; Wang G; Li C; Shan X; Liu H
    Oncol Rep; 2015 Jul; 34(1):272-8. PubMed ID: 25998224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo.
    Sun J; Zhang Y; Zhen Y; Cui J; Hu G; Lin Y
    Oncol Rep; 2019 Dec; 42(6):2345-2354. PubMed ID: 31638254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.
    Cao S; Zheng J; Liu X; Liu Y; Ruan X; Ma J; Liu L; Wang D; Yang C; Cai H; Li Z; Feng Z; Xue Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):37. PubMed ID: 30691465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway.
    Sun L; Liang H; Yu W; Jin X
    Cancer Gene Ther; 2019 May; 26(5-6):136-144. PubMed ID: 30361508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.
    Miao F; Cui C; Zuo D; Zhang H; Mei P; Chen H; Wei S; Yang F; Zheng J; Bai J; Fan Y
    J Neurooncol; 2019 Jun; 143(2):221-229. PubMed ID: 30997639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effect of knocking down microRNA-221 and microRNA-222 on glioma cell growth in vitro and in vivo].
    Zhang CZ; Kang CS; Pu PY; Wang GX; Jia ZF; Zhang AL; Han L; Xu P
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):721-6. PubMed ID: 20021821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
    Wei Y; Wang F; Sang B; Xu Z; Yang D
    Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
    Zhao Z; Zhang L; Yao Q; Tao Z
    Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
    Choi C; Xu X; Oh JW; Lee SJ; Gillespie GY; Park H; Jo H; Benveniste EN
    Cancer Res; 2001 Apr; 61(7):3084-91. PubMed ID: 11306491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
    Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H
    Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.
    Morelli MB; Nabissi M; Amantini C; Tomassoni D; Rossi F; Cardinali C; Santoni M; Arcella A; Oliva MA; Santoni A; Polidori C; Mariani MP; Santoni G
    Oncotarget; 2016 Jul; 7(28):43654-43668. PubMed ID: 27248469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.